ChemBK
  • Home
  • Product Category
  • CHN
  1. Home
  2. CAS 1169956-08-4
  3. Supplier List
  4. MedChemExpress (MCE)
  5. Inhibitory Antibodies
  6. Ocaratuzumab

Request for quotation








Supplier Contact

Supplier NameMedChemExpress (MCE)
Contactsales
Tel609-228-6898
Mobile609-228-6898
QQ
Emailsales@medchemexpress.com; tech@medchemexpress.com
Websitehttps://www.medchemexpress.com/
Wechat
Product NameOcaratuzumab
SynonymsOcaratuzumab
CAS1169956-08-4
EINECS
Chemical Formula
Molecular Weight
inchi
Package1 mg;5 mg
PriceEmail to quote
DescriptionsOcaratuzumab

Ocaratuzumab

MedChemExpress (MCE)

HY-P99308

1169956-08-4

AME 133v

Descriptions

Ocaratuzumab

Ocaratuzumab

MedChemExpress (MCE)

HY-P99308

1169956-08-4

AME 133v
LY 2469298
Humanized Anti-MS4A1 Recombinant Antibody

95.00%

Please store the product under the recommended conditions in the Certificate of Analysis.

Ocaratuzumab (AME 133v) is an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, with a Kd of ~100 pM. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC).

AME-133v (0.027-20 μg/mL) concentration-dependently inhibits the binding of biotinylated Rituximab to CD20 in SKW6.4 cells[1].

Kd: ~100 pM (CD20)[1] In Vitro AME-133v (0.027-20 μg/mL) concentration-dependently inhibits the binding of biotinylated Rituximab to CD20 in SKW6.4 cells[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Ocaratuzumab Related Antibodies

Humanized

Human IgG1 kappa

Human IgG1 kappa, Isotype Control

| | | |

| | | | | |



[1]. Forero-Torres A, et, al. Results of a phase 1 study of AME-133v (LY2469298), an Fc-engineered humanized monoclonal anti-CD20 antibody, in FcγRIIIa-genotyped patients with previously treated follicular lymphoma. Clin Cancer Res. 2012 Mar 1
18(5):1395-403.
[Content Brief]

[2]. Cheney CM, et, al. Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia. MAbs. 2014 May-Jun
6(3):749-55.
[Content Brief]

Supplier Websitehttps://www.medchemexpress.com/ocaratuzumab.html
Last Update2025-05-21 16:50:25
MedChemExpress (MCE) also provides

Depatuxizumab

Category: Inhibitory Antibodies
CAS: 1471999-69-5
Last Update: 2025-05-21 16:50:25

Raxibacumab

Category: Inhibitory Antibodies
CAS: 565451-13-0
Last Update: 2025-05-21 16:50:25

Crizanlizumab

Category: Inhibitory Antibodies
CAS: 1690318-25-2
Last Update: 2025-05-21 16:50:25

Sofituzumab vedotin

Category: Inhibitory Antibodies
CAS: 1418200-58-4
Last Update: 2025-05-21 16:50:25

Fazpilodemab

Category: Inhibitory Antibodies
CAS: 2517935-02-1
Last Update: 2025-05-21 16:50:25

Osemitamab

Category: Inhibitory Antibodies
CAS: 2460539-61-9
Last Update: 2025-05-21 16:50:25

Visugromab

Category: Inhibitory Antibodies
CAS: 2556646-63-8
Last Update: 2025-05-21 16:50:25

Vobramitamab

Category: Inhibitory Antibodies
CAS: 2490556-50-6
Last Update: 2025-05-21 16:50:25
  • Home
  • Product Category

© 2015 ChemBK.com All Rights Reserved | Build: 20150530002